Shares of HealthSouth Corporation (NYSE:HLS) have been assigned an average recommendation of “Hold” from the ten analysts that are currently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and three have given a buy recommendation to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $49.83.

A number of brokerages have recently commented on HLS. ValuEngine cut HealthSouth Corporation from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Stephens began coverage on HealthSouth Corporation in a research report on Thursday, August 31st. They issued an “overweight” rating and a $53.00 price target on the stock. Royal Bank Of Canada reissued a “buy” rating and issued a $55.00 price target on shares of HealthSouth Corporation in a research report on Wednesday, September 6th. KeyCorp reissued a “hold” rating on shares of HealthSouth Corporation in a research report on Thursday, September 7th. Finally, Zacks Investment Research raised HealthSouth Corporation from a “hold” rating to a “buy” rating and set a $55.00 price target on the stock in a research report on Thursday, June 29th.

COPYRIGHT VIOLATION NOTICE: This article was first reported by Daily Political and is owned by of Daily Political. If you are reading this article on another site, it was illegally stolen and reposted in violation of U.S. and international copyright legislation. The original version of this article can be viewed at https://www.dailypolitical.com/2017/09/22/analysts-set-healthsouth-corporation-hls-price-target-at-49-83.html.

HealthSouth Corporation (HLS) traded up 1.08% on Friday, hitting $43.91. The stock had a trading volume of 612,016 shares. The company has a market cap of $4.34 billion, a P/E ratio of 15.46 and a beta of 0.59. The stock has a 50 day moving average price of $44.26 and a 200 day moving average price of $44.95. HealthSouth Corporation has a 1-year low of $36.97 and a 1-year high of $49.71.

HealthSouth Corporation (NYSE:HLS) last posted its earnings results on Monday, July 31st. The company reported $0.71 earnings per share for the quarter, topping analysts’ consensus estimates of $0.68 by $0.03. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The firm had revenue of $981.30 million for the quarter, compared to the consensus estimate of $976.46 million. During the same quarter in the prior year, the business earned $0.69 EPS. The business’s revenue for the quarter was up 6.6% on a year-over-year basis. On average, equities research analysts expect that HealthSouth Corporation will post $2.71 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Monday, October 2nd will be given a $0.25 dividend. This is a boost from HealthSouth Corporation’s previous quarterly dividend of $0.24. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date of this dividend is Friday, September 29th. HealthSouth Corporation’s payout ratio is currently 35.29%.

In related news, CEO Mark J. Tarr sold 22,625 shares of the company’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $43.00, for a total value of $972,875.00. Following the transaction, the chief executive officer now directly owns 283,134 shares of the company’s stock, valued at approximately $12,174,762. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.60% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in HealthSouth Corporation by 4.6% in the 2nd quarter. Vanguard Group Inc. now owns 7,532,456 shares of the company’s stock valued at $364,571,000 after acquiring an additional 328,081 shares in the last quarter. William Blair Investment Management LLC lifted its position in HealthSouth Corporation by 13.9% in the 2nd quarter. William Blair Investment Management LLC now owns 4,302,756 shares of the company’s stock valued at $208,253,000 after acquiring an additional 525,767 shares in the last quarter. State Street Corp lifted its position in HealthSouth Corporation by 7.5% in the 2nd quarter. State Street Corp now owns 3,129,781 shares of the company’s stock valued at $151,479,000 after acquiring an additional 219,306 shares in the last quarter. Voya Investment Management LLC lifted its position in HealthSouth Corporation by 4.4% in the 2nd quarter. Voya Investment Management LLC now owns 1,621,585 shares of the company’s stock valued at $78,485,000 after acquiring an additional 68,486 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its position in HealthSouth Corporation by 1.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,458,636 shares of the company’s stock valued at $70,597,000 after acquiring an additional 23,480 shares in the last quarter. 93.04% of the stock is currently owned by institutional investors and hedge funds.

HealthSouth Corporation Company Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Analyst Recommendations for HealthSouth Corporation (NYSE:HLS)

Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.